Sitting at 348. It looks like BIIB is going to his 350 much faster than even I thought.
He's not taking over anything, he's just joining the BOD.
Based on the way your post you sound like a 14 y/o pimply-faced boy living in his mommy's basement. Go back to your xbox until you go through puberty.
I will look for those. The only study that I was able to find was a phase III with only 180 participants and no information on the outcome.
BIIB's up to 330 today. Looks like the OP's prediction was wrong and I am going to be right.
Eloctate, Alprolux, Pleglridy. etc. BIIB has had multiple FDA filings over the past 12-18 months and they will become revenue streams as they roll out.
BIIB is going to hit $350 long before it hits $250. If you're shorting it you are going to lose your shorts.